Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
Vuh4YX4LYyPurqVG
Listen
